Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study.

Asmaa M ZahranHelal F HettaShimaa MansourEreny S SaadAmal Rayan

Published in: Cancer immunology, immunotherapy : CII (2020)

Despite the controversy about the prognostic role of pDCs not only in NSCLC but also in other solid tumors, our study sheds light on the possible prognostic impact of pDCs and mDCs on treatment outcomes of NSCLC patients.

Keyphrases

dendritic cells
small cell lung cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
immune response
advanced non small cell lung cancer
patient reported outcomes